ArticleCancers2020

Exploiting GRK2 Inhibition as a Therapeutic Option in Experimental Cancer Treatment: Role of p53-Induced Mitochondrial Apoptosis.

Jessica Gambardella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.